Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Glenmark Pharmaceuticals prepares new MPGES-1 inhibitors

Sep. 10, 2012

Novel DGAT1 inhibitors synthesized by Merck & Co.

Sep. 10, 2012

CSIR patents novel agents for cancer

Sep. 10, 2012

Novel HDAC inhibitors prepared at Dana Farber Cancer Institute

Sep. 10, 2012

UPenn patents new vaccines for HBV

Sep. 7, 2012

Roche and Siena Biotech disclose novel BACE inhibitors

Sep. 7, 2012

Roche synthesizes new dual D3/5-HT2A receptor ligands

Sep. 7, 2012

Canadian group patents novel antimicrobial steroid alkaloids

Sep. 7, 2012

Indian researchers disclose novel DNA alkylating agents

Sep. 7, 2012

Novel S1P4 receptor antagonists synthesized by Biogen Idec

Sep. 6, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...